Please use this identifier to cite or link to this item:
https://olympias.lib.uoi.gr/jspui/handle/123456789/18260Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.contributor.author | Alexiou, G. | en |
| dc.contributor.author | Tsiouris, S. | en |
| dc.contributor.author | Fotopoulos, A. | en |
| dc.date.accessioned | 2015-11-24T18:51:26Z | - |
| dc.date.available | 2015-11-24T18:51:26Z | - |
| dc.identifier.issn | 1790-5427 | - |
| dc.identifier.uri | https://olympias.lib.uoi.gr/jspui/handle/123456789/18260 | - |
| dc.rights | Default Licence | - |
| dc.subject | Brain Neoplasms/pathology/radionuclide imaging | en |
| dc.subject | Cerebral Hemorrhage/pathology/radionuclide imaging | en |
| dc.subject | Diagnosis, Differential | en |
| dc.subject | Glioma/pathology/radionuclide imaging | en |
| dc.subject | Humans | en |
| dc.subject | Meningioma/pathology/radionuclide imaging | en |
| dc.subject | Necrosis/pathology/radionuclide imaging | en |
| dc.subject | Recurrence | en |
| dc.subject | Tomography, Emission-Computed, Single-Photon/methods | en |
| dc.title | Single-photon emission computed tomography in the evaluation of brain tumors and the diagnosis of relapse vs radiation necrosis | en |
| heal.type | journalArticle | - |
| heal.type.en | Journal article | en |
| heal.type.el | Άρθρο Περιοδικού | el |
| heal.identifier.secondary | http://www.ncbi.nlm.nih.gov/pubmed/18084668 | - |
| heal.language | el | - |
| heal.access | campus | - |
| heal.recordProvider | Πανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικής | el |
| heal.publicationDate | 2007 | - |
| heal.abstract | Morphologic characterization of brain tumors by magnetic resonance imaging and computed tomography is well established. However, functional metabolic imaging by single-photon emission tomography (SPET) and positron emission tomography are also increasingly important imaging tools for noninvasive assessment of brain tumors. Brain SPET is useful in the differentiation of tumor recurrence from radiation necrosis, in the non-invasive assessment of gliomas and meningiomas aggressiveness, in differentiating neoplastic from non neoplastic intracerebral haemorrhage, in monitoring therapy response and in the evaluation of other types of brain tumors. Our own experience is presented supporting the above. | en |
| heal.journalName | Hell J Nucl Med | en |
| heal.journalType | peer-reviewed | - |
| heal.fullTextAvailability | TRUE | - |
| Appears in Collections: | Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ | |
Files in This Item:
There are no files associated with this item.
This item is licensed under a Creative Commons License
